Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Laboratory Developed Test Market : Global Industry Analysis and forecast 2028

Author: Sahil Pawar
by Sahil Pawar
Posted: Oct 22, 2022

Laboratory Developed Test Market Analysis Overview:

Clinical biochemistry is expected to support the growth of the type segment in the laboratory development test market. Clinical biochemistry includes screening and measurement of chemicals in body fluids, blood, and urine samples. These test results are used to identify health problems and for early detection of chronic disease. This in turn is driving the market growth.

In a recent research report by Market Research Community, the Laboratory Developed Test (LDT) Market is expected to surpass USD 7.77 Billion by the year 2028, from USD 4.87 Billion in 2021.

is employed to evaluate or detect several substances from the human body such as chemical compounds like glucose, cholesterol, DNA, and proteins. Some lab detection tests are simple, and measure single analytes such as the Sodium level and some are complex that detect DNA, RNA, and others.

Top Key Players of the Laboratory Developed Test Market:

Quest Diagnostics Incorporated F. HOFFMANN-LA ROCHE LTD., QIAGEN, Illumina, Inc., Eurofins Scientific, Biodesix, Adaptive Biotechnologies, Biotheranostics, Rosetta Genomics Ltd., Guardant Health.

In the regional segment, Europe is expected to be the potential segment in the laboratory development test market. The factors surging the growth of the market are surgical procedures, road accidents, and the launch of technologically advanced products. Further, the Asia Pacific is projected to support the growth of the market due to the rising patient pool and growing medical tourism in the region.

The market is projected to grow at a significant pace reaching a CAGR of approximately 6.9%, over the forecast period of 2022–2028, despite a considerable fall in Service Operator sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.

Type Covered in This Report Are:

Clinical Biochemistry

Molecular Diagnostics

Immunology

Critical Care

Microbiology

Haematology

Others

On the Basis of Application:

Hospitals laboratory

Specialty Diagnostic Centers

Clinical Research organizations

Academic Institutes

Others

Regional Analysis:

North America– (U.S., Canada, Mexico)

Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)

Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)

Latin America- (Brazil, Argentina, Chile, Rest of Latin America)

Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)

The study is consolidated into major segments and further into sub-segments, such as by Type (Clinical Biochemistry, Molecular Diagnostics, Immunology, Critical Care, Microbiology, Haematology, Others), By Application (Hospitals laboratories, Specialty Diagnostic Centers, Clinical Research organizations, Academic Institutes, Others), to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.

Contact:

https://marketresearchcommunity.com/

sales@marketresearchcommunity.com

About the Author

Https://marketresearchcommunity.com/

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Sahil Pawar

Sahil Pawar

Member since: Jul 21, 2022
Published articles: 1

Related Articles